Basic Information

Reference Number

0000281224

Issuing Organization

Canada’s Drug Agency

Solicitation Type

RFP - Request for Proposal (Formal)

Solicitation Number

C-242503040

Title

Forecasting Submissions

Source ID

PP.CO.ON.786141.C2573801

Details

Location

Canada, Ontario, Ottawa

Delivery Point

600-865 Carling Ave
Ottawa, Ontario
Canada K1S 5S8

Purchase Type

Term: 2024/12/16 12:00:00 AM EST - 2025/03/31 12:00:00 AM EDT

Description

An overview of our requirements is outlined below. For more information and Proposal submission instructions, refer to the RFP main document. Additional instructions may get published in Bulletins.

Through Health Technology Assessment (HTA), Canada's Drug Agency (CDA-AMC) appraise a drug or technology’s effectiveness against other treatment options and produce a recommendation to inform decisions on public reimbursement. We would like to accurately forecast drug HTA submissions that we are expected to receive from an industry sponsor in the near-term (6-months/1-year), mid-term (3-years) and long-term (5-years).

Dates

Publication

2024/10/31 01:19:20 PM EDT

Bid Intent

Optional

Bid Intent Deadline

2024/11/06 11:59:00 PM EST

Question Acceptance Deadline

2024/11/08 02:00:00 PM EST

Questions are submitted online

Closing Date

2024/11/22 02:00:00 PM EST

Bid Submission Process

Bid Submission Type

Physical Bid Submission

Additional Bidding Instructions

The point of contact for all Enquiries and Proposal Submissions is the following:

• By email to contracts@cda-amc.ca.

© MERX - All rights reserved. No part of the information on this Web Site may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of MERX and the Minister of the participating government department (if applicable). MERX, the Minister nor the Contracting Authority will assume responsibility or liability for the accuracy of the information contained in the publication.